Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
ClinicalTrials.gov study NCT02874807. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
ClinicalTrials.gov study NCT03227484. IPD Sharing: NO. Countries: 1. Publications: 2.
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
ClinicalTrials.gov study NCT05977465. IPD Sharing: YES. Countries: 1. Publications: 1.
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
ClinicalTrials.gov study NCT04061200. IPD Sharing: NO. Countries: 1. Publications: 2.
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects
ClinicalTrials.gov study NCT03485092. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
ClinicalTrials.gov study NCT03933956. IPD Sharing: NO. Countries: 1. Publications: 7.
The Effects of Empagliflozin on Arterial Wall Characteristics
ClinicalTrials.gov study NCT03639545. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
ClinicalTrials.gov study NCT06706791. IPD Sharing: NO. Countries: 1. Publications: 8.
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
ClinicalTrials.gov study NCT05610956. IPD Sharing: YES. Countries: 1. Publications: 15.
Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
ClinicalTrials.gov study NCT05078879. IPD Sharing: NO. Countries: 1. Publications: 3.
Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
ClinicalTrials.gov study NCT04911660. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
ClinicalTrials.gov study NCT05373680. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
ClinicalTrials.gov study NCT05510115. IPD Sharing: YES. Countries: 1. Publications: 3.
Empagliflozin and Renal Oxygenation in Healthy Volunteers
ClinicalTrials.gov study NCT03093103. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
ClinicalTrials.gov study NCT05605158. IPD Sharing: Not stated. Countries: 1. Publications: 21.
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
ClinicalTrials.gov study NCT02471963. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
ClinicalTrials.gov study NCT06046612. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02964715. IPD Sharing: NO. Countries: 1. Publications: 11.
The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure
ClinicalTrials.gov study NCT05042973. IPD Sharing: NO. Countries: 1. Publications: 1.
Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
ClinicalTrials.gov study NCT01001962. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.